Redcliffe Labs
Redcliffe Labs is an India-based omnichannel diagnostics platform offering pathology and radiology services through 80+ self-owned labs, 2,000+ collection centres, and India's widest home sample-collection network across 220+ cities, serving over 1 crore individual consumers primarily in Tier 2-4 markets.
- Company typePrivate
- Founded2021
- HeadquartersNoida, India
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Redcliffe Labs does
Redcliffe Labs (legally Redcliffe Lifetech Private Limited) is an India-based omnichannel diagnostics platform offering pathology and radiology services through a nationwide network of 80+ self-owned certified laboratories and 2,000+ collection centres across 220+ cities and 4,000+ pin codes, with a particular concentration in Tier 2/3/4 markets that account for over 70% of diagnostic volumes. The company runs India's widest home sample-collection network through trained phlebotomists and an omnichannel booking stack spanning website, mobile app, phone, and WhatsApp, while processing 70,000+ tests daily across a 3,600+ test menu that includes routine pathology and genetic testing. Technology investments include AI-powered smart reports with colour-coded insights and simplified summaries, drone-based sample transport (including India's first commercial medical drone corridor between Uttarkashi and Dehradun), AI-powered facial scan for instant wellness screening, temperature-controlled logistics with real-time monitoring, and QR-coded report verification.
The business model is a hybrid of transactional test fees, health package sales, and subscription/membership programmes (VIP, VIP Gold, One Health Plan), supplemented by gift cards and corporate-wellness contracts. Brand portfolio extends beyond core pathology to Femcliffe (women's health), GeneCliffe and its genetic sub-brands (CardioCliffe, OncoCliffe, NeuroCliffe, ReproCliffe, NephroCliffe, GutMicrobiome, Health EX), and the recently launched Annual Health Report Card for longitudinal tracking. Acquisitions of Medicentre Sonography & Clinical Lab (Southern Rajasthan, 2023), Celara Diagnostics (Bengaluru, 2024) and a high-end imaging centre in Ajmer (2026) underpin an inorganic roll-up into integrated radiology + pathology ecosystems across India.
The customer base of 1 crore+ (10M+) is long-tailed, dominated by individual consumers using both transactional preventive packages (₹997-₹1,799 typical full-body bundles, advertised at 64-79% off MRP) and subscription programmes, with secondary segments in corporate wellness and healthcare-provider referrals. Redcliffe has raised approximately $103M cumulatively across multiple rounds including a $61M Series B (May 2022, LeapFrog-led) and a $42M Series C (September 2024, IFU-led). FY25 revenue stood at ₹419 crore (up 20% YoY), with EBITDA losses reduced from -38% to -21% and a stated path to EBITDA-positive by H2 FY26 alongside a FY26 revenue target of ₹560 crore. Divestiture of Crysta IVF to Moon Care (2026) sharpens focus on core diagnostics, while new C-suite hires including a dedicated Chief Business Officer for Inorganic Growth formalise continued M&A-led expansion and a potential future IPO.
Redcliffe Labs firmographics
Firmographics- Name
- Redcliffe Labs
- Legal name
- Redcliffe Lifetech Private Limited
- Website
- https://redcliffelabs.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Redcliffe Labs is an India-based omnichannel diagnostics platform offering pathology and radiology services through 80+ self-owned labs, 2,000+ collection centres, and India's widest home sample-collection network across 220+ cities, serving over 1 crore individual consumers primarily in Tier 2-4 markets.
- Ownership category
- akta.pro rank
Redcliffe Labs industry classification
Industry- Product category
- Diagnostic Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Reference & Esoteric Testing Laboratories (HLAFAMAJ)
- akta.pro secondary industries
- Genetic & Prenatal Testing Laboratories (HLAFAMAH), Lab Draws, Specimen Collection & Point-of-Care Testing (In-Home) (HSABACAN), At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
Keywords
Where Redcliffe Labs is headquartered
LocationHeadquarters
- HQ city
- Noida
- HQ country
- India
- HQ region
- Asia
Offices5 records
Markets served
Redcliffe Labs business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Diagnostic Testing Services: Pathology and genetic testing services offered through 3,600+ tests across 80+ labs. Revenue from individual test bookings and health packages.
- Health Packages: Curated diagnostic health packages including full body checkups, organ-specific tests, and preventive screening packages
- VIP Membership Programs: VIP membership offering 10% discount across pathology tests, free sample collection for premium slots, RedCash loyalty rewards
- One Health Subscription: Annual subscription plan with 15 free tests up to Rs 1,500 per order plus initial full body health checkup
- Gift Cards: Gift cards sold for diagnostic services on website and mobile app, valid for 12 months from issuance
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Fit India Full Body Checkup - Essential |
| Unit Pricing | Pay-as-you-go | Smart Full Body Checkup |
| Unit Pricing | Pay-as-you-go | Annual Full Body Checkup - Advance |
| Unit Pricing | Pay-as-you-go | Thyroid Screening Panel |
| Subscription | Annual | VIP Membership |
| Subscription | Multi-year contract | VIP Gold Membership |
| Subscription | Annual | One Health Plan |
| Unit Pricing | Pay-as-you-go | Group Booking Discounts |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels9 records
Redcliffe Labs product offering
Product offeringCore offering
Redcliffe Labs operates an omnichannel diagnostics platform offering pathology and radiology services, with 3,600+ tests available across 80+ self-owned certified laboratories and a home sample collection network spanning 220+ Indian cities. Customers can book individual tests, doctor-curated health packages, genetic tests (GeneCliffe) and women's health packages (Femcliffe) online or via phone/WhatsApp, with phlebotomists collecting samples at home in temperature-controlled bags and reports delivered digitally with AI-generated summaries.
Differentiator
Problem solved
Functional benefit
Brands
- GeneCliffe: Genetic testing platform offering DNA, chromosome and protein analysis for personalized health insights including CardioCliffe, NephroCliffe, Health EX, GutMicrobiome, ReproCliffe, OncoCliffe, and NeuroCliffe
- Femcliffe
- CardioCliffe
- NephroCliffe
- OncoCliffe
- NeuroCliffe
- ReproCliffe
- GutMicrobiome
- Health EX
Products and services
- Pathology and Diagnostic Testing Services Core pathology, haematology, biochemistry, microbiology and genetic testing services delivered through self-owned labs across 220+ Indian cities for individual consumers, referring doctors and corporate customers.
- Doctor-Curated Health Checkup Packages Curated multi-parameter preventive health packages such as Fit India Full Body Checkup - Essential (94 parameters), Smart Full Body Checkup (89 parameters) and Annual Full Body Checkup - Advance (96 parameters), targeting individual consumers and families for routine and preventive screening.
- Home Sample Collection Service Trained phlebotomist-led home visit sample collection across 220+ cities and 4,000+ pin codes using temperature-controlled bags and real-time temperature monitoring, available via website, mobile app, phone and WhatsApp booking.
- GeneCliffe Genetic Testing Platform Genetic testing umbrella offering DNA, chromosome and protein-based personalised health insights through specialised products including CardioCliffe, NephroCliffe, NeuroCliffe, OncoCliffe, ReproCliffe, GutMicrobiome and Health EX.
- Femcliffe Women's Health Diagnostic Platform India's first she-centric diagnostic platform offering women-specific health packages, cervical cancer screening (HPV and pap smear tests), and reproductive health diagnostics targeted at female consumers.
- Redcliffe Medicentre Imaging & Labs (Radiology Services) Radiology and advanced imaging services offered through the acquired Medicentre Imaging & Labs facility in Ajmer, complementing Redcliffe's pathology offerings across India.
- AI-Powered Face Scan Wellness Screening AI computer-vision based facial scan offering instant wellness screening and health risk assessment for consumers, deployed as a top-of-funnel screening tool in campaigns.
- Annual Health Report Card India's first annual health report card providing a consolidated longitudinal view of an individual's health parameters, vitals, health scores and trend analysis tracked throughout the year.
- VIP Membership Program Recurring membership programme offering 10% discount across pathology tests, free sample collection for premium slots, up to 10 bookings per month at no convenience fee, and RedCash loyalty rewards for individual consumers.
- One Health Annual Subscription Plan Annual subscription for individual consumers including one initial full body checkup and 15 free tests up to ₹1,500 per order during the one-year validity, designed to drive recurring preventive testing.
- Redcliffe Labs Gift Cards Gift cards sold through the website and mobile app that can be redeemed against Redcliffe Labs' diagnostic services, valid for 12 months from issuance.
Quantifiable outcome
- Reports delivered within 14 hours of sample collection
- +3 more outcomes
Companies that use Redcliffe Labs
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles3 records
Redcliffe Labs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature6 records
Redcliffe Labs partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Medicentre Sonography and Clinical Lab (Ajmer)coreAcquired leading diagnostic centre in Ajmer, Rajasthan operating as Redcliffe Medicentre Imaging & Labs. Facility equipped with 1.5 Tesla MRI and 128-slice CT scan, capable of over 1,200 MRI and 1,500 CT scans monthly.
- Celara DiagnosticscoreAcquired Bengaluru-based diagnostics chain with two high-end diagnostic centers and over 3,600 tests. Expands radiology and pathology services into South India. Brought on experts Dr. Radhesh S. and Dr. Rekha Radhesh.
- Medicentre Sonography & Clinical LabcoreAcquired largest independent diagnostic lab chain in Southern Rajasthan to position Redcliffe as largest integrated lab chain in Rajasthan. Deal involved mix of cash and equity.
Scale indicators15 records
Recent moves6 records
Expansion highlights6 records
Redcliffe Labs competitors and assessment
Company assessmentDirect peers
- Pathkind Labs: Indian diagnostics chain expanding aggressively in Tier 2/3 markets with home collection and B2B partnerships. Comparable growth-stage omnichannel model targeting similar underserved geographies.
- Dr. Lal PathLabs: Largest organized diagnostics chain in India, offering pathology and radiology across thousands of collection centres. Direct competitor in routine and preventive testing, with overlapping Tier 2/3 footprint and a stronger metro brand.
- Metropolis Healthcare: Pan-India diagnostic chain with strong presence in B2B hospital partnerships and B2C testing. Competes directly with Redcliffe on pathology menu, preventive health packages, and Tier 2/3 city expansion.
- Agilus Diagnostics (SRL Diagnostics): Large Indian diagnostics network offering pathology, radiology, and home sample collection. Closely comparable on omnichannel model and is actively pursuing inorganic expansion — directly overlapping Redcliffe's roll-up strategy.
- Thyrocare Technologies: Preventive-focused diagnostics chain owned by PharmEasy, known for low-cost routine and preventive packages. Competes on price-sensitive preventive health checkups — a core Redcliffe offering.
- Apollo Diagnostics: Diagnostics arm of Apollo Hospitals, offering pathology, imaging, and home collection across India. Comparable on integrated diagnostics + hospital referral model, with stronger hospital-anchored B2B demand.
- Healthians: Digital-first Indian diagnostics platform focused on home sample collection and preventive packages. Closely comparable GTM motion and Tier 2/3/4 customer base, competing head-on in the omnichannel home-collection segment.
- Tata 1mg (1mg Diagnostics): Digital health platform offering diagnostics, pharmacy, and teleconsultation. Competes with Redcliffe on D2C online booking, package-based preventive testing, and home sample collection.
- Suburban Diagnostics: Established Indian diagnostics provider with pathology, radiology, and home collection. Overlaps with Redcliffe in routine testing and home sample collection, particularly in western India.
Broad incumbents
- PharmEasy: Digital healthcare platform with diagnostics (via Thyrocare) and pharmacy operations. Adjacent competitor leveraging Thyrocare's lab network for D2C diagnostics packages similar to Redcliffe's preventive offerings.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Redcliffe Labs social profiles
Digital presenceRedcliffe Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Redcliffe Labs leadership team
Management profileNumber of profiles
Profiles9 records
Redcliffe Labs subsidiaries and ownership
Company hierarchySubsidiaries3 records
Redcliffe Labs funding detail
Funding detailFunding overview
Funding rounds7 records
Investors21 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Redcliffe Labs M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Redcliffe Labs
What does Redcliffe Labs do?
Redcliffe Labs operates an omnichannel diagnostics platform offering pathology and radiology services, with 3,600+ tests available across 80+ self-owned certified laboratories and a home sample collection network spanning 220+ Indian cities. Customers can book individual tests, doctor-curated health packages, genetic tests (GeneCliffe) and women's health packages (Femcliffe) online or via phone/WhatsApp, with phlebotomists collecting samples at home in temperature-controlled bags and reports delivered digitally with AI-generated summaries.
Is Redcliffe Labs a public or private company?
Redcliffe Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was Redcliffe Labs founded?
Redcliffe Labs was founded in 2021. It employs 1,001 to 5,000 people.
Where is Redcliffe Labs based?
Redcliffe Labs is headquartered in Noida, India, in the Asia region.
How does Redcliffe Labs make money?
Five revenue lines are on record. Diagnostic Testing Services are the primary driver. The others are health Packages, VIP Membership Programs, one Health Subscription and gift Cards.
Who are Redcliffe Labs's main competitors?
Direct peers on record are Pathkind Labs, Dr. Lal PathLabs, Metropolis Healthcare, Agilus Diagnostics (SRL Diagnostics), Thyrocare Technologies, Apollo Diagnostics, Healthians, Tata 1mg (1mg Diagnostics) and Suburban Diagnostics. PharmEasy is listed as a broad incumbent.
Does Redcliffe Labs have an API?
No public API is recorded for Redcliffe Labs.
What industry is Redcliffe Labs in?
Redcliffe Labs's product category is Diagnostic Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAFAMAH, Genetic & Prenatal Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.